New dementia drugs: patients to pay privately or face NHS postcode lottery
The Guardian - Pharmaceutical Industry
JULY 15, 2023
As advanced remedies emerge, the chief executive of Alzheimer’s Research UK warns sufferers could miss out as the health service struggles to cope Groundbreaking new dementia drugs are likely to be the preserve of the rich while NHS patients will be subject to a “massive postcode lottery” when they become available for the first time in the UK, according to the co-chair of the government’s national mission to tackle the condition.
Let's personalize your content